New CEO To Lead Atlas Genetics' Commercial Phase

Atlas Genetics has appointed a new CEO, as the specialist in point-of-care molecular diagnostics moves to the next phase of commercialization of its io system.

Atlas Genetics Ltd. has appointed Jeffrey Luber CEO. He succeeds John Clarkson, who founded Atlas Genetics and who will now take on the role of executive chairman. Current chairman, Neil Butler, will remain with UK company as a non-executive board director.

Luber has led both public and private companies; he was most recently with Good Start Genetics where he restored growth...

More from In Vitro Diagnostics

More from Diagnostics